FEED · ENvue Medical, Inc.
$4.05
-0.06 (-1.46%)
At close · Sep 3
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we do not have sufficient resources to fund our operations for the next twelve months from the date of this filing causing us to have substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$3.98M
Shares
923,718
FEED metrics
48 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$4.11
Market cap
$3.98M
Price action
19 metricsPrice change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
923,718
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.1×
reciprocal yield 48.4%
P / book
0.1
reciprocal yield 772.6%
FCF yield
-295.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-529.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.6%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 54.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-26.1%
Operating margin
-1,362.7%
Trailing 12 months
Net margin
-1,093.6%
Gross profit (TTM)
−$502,000
Operating profit (TTM)
−$26.25M
Net income (TTM)
−$21.06M
Trailing 12 months
Diluted EPS (TTM)
$-55.44
FCF margin
-609.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-51.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.93M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,170.7%
Year over year · more shares
Revenue CAGR (3Y)
+50.3%
Revenue CAGR (5Y)
+32.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-68.5%
Return on assets
-54.8%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
−$25.30M
Free cash flow (TTM)
−$11.74M
Quick ratio
0.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.08M
Total assets
$38.41M
Total debt
$1.25M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$11.65M
Capital expenditures (TTM)
$95,000
R&D (TTM)
$1.19M
SG&A (TTM)
—
Stock compensation (TTM)
$356,000
R&D / revenue
62.0%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
13
13F filer change QoQ
0
Institutional ownership
2.6%
Short interest
3 metricsShort interest
3.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
−$144,480
Insider-sentiment score
35 / 100
Risk flags
1 metricsGoing concern
Flagged